Primed 3D injectable microniches enabling low-dosage cell therapy for critical limb ischemia

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 37, 2014, Pages 13511-13516

  Li, Yaqian ^a,b   Liu, Wei ^a   Liu, Fei ^a,c   Zeng, Yang ^a   Zuo, Simin ^a   Feng, Siyu ^d   Qi, Chunxiao ^a   Wang, Bingjie ^a   Yan, Xiaojun ^a   Khademhosseini, Ali ^e,f,g,h,i   Bai, Jing ^a   Du, Yanan ^a,b  

^a Tsinghua University   (China)

^b ZHEJIANG UNIVERSITY   (China)

^c Tsinghua University   (China)

^d BEIHANG UNIVERSITY   (China)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

^f MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^g HARVARD UNIVERSITY   (United States)

^h BK 21 Plus   (South Korea)

ⁱ KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; CRYOGEL; GELATIN;

ANGIOGENESIS; ANIMAL; CELL CULTURE; CELL SURVIVAL; CRYOGEL; CYTOLOGY; DRUG EFFECTS; FIBROSIS; FLUORESCENCE; HINDLIMB; HUMAN; INJECTION; ISCHEMIA; LIMB SALVAGE; LUMINESCENCE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; METABOLISM; MOUSE; MUSCLE; PATHOLOGY; PHARMACOLOGY; STEM CELL NICHE; VASCULARIZATION;

ANGIOGENESIS INDUCING AGENTS; ANIMALS; CELL SURVIVAL; CELLS, CULTURED; CRYOGELS; FIBROSIS; FLUORESCENCE; GELATIN; HINDLIMB; HUMANS; INJECTIONS; ISCHEMIA; LIMB SALVAGE; LUMINESCENT MEASUREMENTS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; MUSCLES; NEOVASCULARIZATION, PHYSIOLOGIC; STEM CELL NICHE;

EID: 84907200636     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1411295111     Document Type: Article

References (29)

1. Gimble JM, Guilak F, Bunnell BA (2010) Clinical and preclinical translation of cell-based therapies using adipose tissue-derived cells. Stem Cell Res Ther 1(2):19.
2. Sheikh AY, et al. (2007) Molecular imaging of bone marrow mononuclear cell homing and engraftment in ischemic myocardium. Stem Cells 25(10):2677-2684.
3. Amado LC, et al. (2005) Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc Natl Acad Sci USA 102(32): 11474-11479.
4. Cheng AY, García AJ (2013) Engineering the matrix microenvironment for cell delivery and engraftment for tissue repair. Curr Opin Biotechnol 24(5):864-871.
5. Freyman T, et al. (2006) A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction. Eur Heart J 27(9): 1114-1122.
6. Thai HM, et al. (2009) Implantation of a three-dimensional fibroblast matrix improves left ventricular function and blood flow after acute myocardial infarction. Cell Transplant 18(3):283-295.
7. Liu W, et al. (2014) Microcryogels as injectable 3-D cellular microniches for site-directed and augmented cell delivery. Acta Biomater 10(5):1864-1875.
8. Lawall H, Bramlage P, Amann B (2010) Stem cell and progenitor cell therapy in peripheral artery disease. A critical appraisal. Thromb Haemost 103(4):696-709.
9. Zhang L, et al. (2011) Delayed administration of human umbilical tissue-derived cells improved neurological functional recovery in a rodent model of focal ischemia. Stroke 42(5):1437-1444.
10. Kim H, et al. (2010) Dose-dependent efficacy of ALS-human mesenchymal stem cells transplantation into cisterna magna in SOD1-G93A ALS mice. Neurosci Lett 468(3): 190-194.
11. Kinnaird T, et al. (2004) Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation 109(12):1543-1549.
12. Vadalà G, et al. (2012) Mesenchymal stem cells injection in degenerated intervertebral disc: cell leakage may induce osteophyte formation. J Tissue Eng Regen Med 6(5):348-355.
13. Seminatore C, et al. (2010) The postischemic environment differentially impacts teratoma or tumor formation after transplantation of human embryonic stem cell-derived neural progenitors. Stroke 41(1):153-159.
14. Hacein-Bey-Abina S, et al. (2003) A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N Engl J Med 348(3):255-256.
15. Moreira Teixeira LS, et al. (2012) High throughput generated micro-aggregates of chondrocytes stimulate cartilage formation in vitro and in vivo. Eur Cell Mater 23: 387-399.
16. Ifkovits JL, et al. (2010) Injectable hydrogel properties influence infarct expansion and extent of postinfarction left ventricular remodeling in an ovine model. Proc Natl Acad Sci USA 107(25):11507-11512.
17. Kuraitis D, Giordano C, Ruel M, Musarò A, Suuronen EJ (2012) Exploiting extracellular matrix-stem cell interactions: a review of natural materials for therapeutic muscle regeneration. Biomaterials 33(2):428-443.
18. Kang Y, et al. (2009) Quantitative analysis of peripheral tissue perfusion using spatiotemporal molecular dynamics. PLoS One 4(1):e4275.
19. Laflamme MA, Murry CE (2005) Regenerating the heart. Nat Biotechnol 23(7): 845-856.
20. Mima Y, et al. (2012) Enhancement of cell-based therapeutic angiogenesis using a novel type of injectable scaffolds of hydroxyapatite-polymer nanocomposite microspheres. PLoS One 7(4):e35199.
21. Bencherif SA, et al. (2012) Injectable preformed scaffolds with shape-memory properties. Proc Natl Acad Sci USA 109(48):19590-19595.
22. Koshy ST, Ferrante TC, Lewin SA, Mooney DJ (2014) Injectable, porous, and cell-responsive gelatin cryogels. Biomaterials 35(8):2477-2487.
23. Lin H, Yang G, Tan J, Tuan RS (2012) Influence of decellularized matrix derived from human mesenchymal stem cells on their proliferation, migration and multi-lineage differentiation potential. Biomaterials 33(18):4480-4489.
24. Cheng K, et al. (2010) Magnetic targeting enhances engraftment and functional benefit of iron-labeled cardiosphere-derived cells in myocardial infarction. Circ Res 106(10):1570-1581.
25. Pasha Z, et al. (2008) Preconditioning enhances cell survival and differentiation of stem cells during transplantation in infarcted myocardium. Cardiovasc Res 77(1):134-142.
26. Behfar A, et al. (2010) Guided cardiopoiesis enhances therapeutic benefit of bone marrow human mesenchymal stem cells in chronic myocardial infarction. J Am Coll Cardiol 56(9):721-734.
27. Wang CH, Wang TM, Young TH, Lai YK, Yen ML (2013) The critical role of ECM proteins within the human MSC niche in endothelial differentiation. Biomaterials 34(17): 4223-4234.
28. Izadpanah R, et al. (2008) Long-term in vitro expansion alters the biology of adult mesenchymal stem cells. Cancer Res 68(11):4229-4238.
29. Li X, et al. (2014) Micro-scaffold array chip for upgrading cell-based high-throughput drug testing to 3D using benchtop equipment. Lab Chip 14(3):471-481.